Pharmaceuticals

Haleon

Salesforce

Conference Minutes

OpenAI

DXYZ

GOOG

GOOGL

INFA

GGLS

GGLL

ARR-C

<p>The following are the minutes of the FY26Q3 earnings call for <span class="security-tag" type="security-tag" counter_id="ST/US/CRM" name="Salesforce" trend="">$Salesforce(CRM.US)</span> compiled by Dolphin Research. For an interpretation of the earnings report, please refer to the article &#34;Salesforce: Is the AI Agent 'Delayed', and Has the SaaS Leader Become a Value Stock?&#34; 1. Review of Core Financial Information Guidance: The company is still expected to reaccelerate revenue growth within the next 12 to 18 months. Net new AOV growth: Net new AOV growth in the second half of FY26 is expected to exceed AOV growth in the second half...</p>

NOVARTIS AG

Destiny Tech100

Alphabet - C

Alphabet

Informatica

IRSA Inversiones

Direxion Daily Googl Bear 1x Shares

Direxion Daily GOOGL Bull 2X Shares

Gartner

Hasbro

ING Groep

Armour Residential Reit

ARMOUR RESIDENTIAL REIT INC 7.00% CUM RED PFD STK SER C

Salesforce (Minutes): The foundation of technology and sales has been laid, looking forward to the harvest period

Berenberg Bank Maintains Buy Rating on Haleon PLC

Hayes Maintains Buy Rating on Haleon PLC

Nicolai Analyzes and Recommends Consumer Staples Industry Stocks

Drive Wealth Management LLC Increases Holdings in Haleon PLC

Haleon collaborates with Sharjah University to enhance UAE healthcare education

David Hayes Upgrades Haleon PLC to Buy with Raised Earnings Forecast

Haleon Chooses Salesforce Life Sciences Cloud to Enhance Customer Engagement

RBC Reiterates Haleon's 'Sector Perform' Rating

Haleon released FY2025 Q1 earnings on July 31 (EST), actual revenue USD 0 (forecast USD 3.706 B), actual EPS USD 0

Haleon released FY2025 Q2 earnings on July 31 After-Market EST, actual revenue USD 3.756 B (forecast USD 3.602 B), actual EPS USD 0.1219

Haleon released FY2025 Semi-Annual earnings on July 31 After-Market (EST), actual revenue USD 7.303 B (forecast USD 7.527 B), actual EPS USD 0.2372

Haleon PLC Gets Buy Recommendations from Several Rating Agencies

Haleon to Release FY2025 Semi-Annual Earnings on July 30, 2025 (EST), Forecast Revenue USD 7.473 B

Haleon PLC Announces Wellington Management's Holding Exceeds 5%

Haleon PLC Receives 'Moderate Buy' Consensus Rating from Multiple Brokers

Haleon Invests £130 Million in Global Oral Health Innovation Center

Alfredresa Medical Signs Disaster Cooperation Agreement with Haleon Japan

Haleon plc Appoints Carl Haney as Chief R&D Officer

Analyst Considers Haleon Undervalued

Haleon PLC Non-Executive Director Purchases Shares

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

禮來

ROCHE HOLDINGS AG

羅氏(ADR)

阿斯利康

諾華制藥

諾和諾德公司

中外制藥(ADR)

UCB(ADR)

第一三共株式會社(ADR)

大塚制藥(ADR)

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio